Clinical Trial Update: A Novel Biologic Therapy for Perennial Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for a novel biologic therapy targeting perennial allergic rhinitis; results completed with posted data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• A Novel Biologic Therapy

Snippet

Sponsor: Johns Hopkins University | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2019-09-04